You are here
- ARGENE® RANGE
Real-time PCR and immunology solutions
Built on more than 25 years of expertise in virological diagnosis, ARGENE® is an innovative and comprehensive range of ready-to-use real-time PCR and immunology solutions for the diagnosis infectious diseases, in particular for:
- Management of viral infections in immunocompromised patients
- Detection of pathogens involved in respiratory tract infections
- Detection of pathogens responsible for central nervous system infections
Do you need more information
ARGENE® real-time PCR provide CE-IVD assays on all major extraction platforms and real-time PCR systems as well as on different sample types. The kits include internal control standards and, for quantitative assays, quantification standards. Offering sensitivity and specificity, ARGENE® real-time PCR kits enable you to provide rapid, reliable results for the management of bacterial and viral infection.
The immunology range offers reference products for the detection of infectious diseases.
With ready-to-use reagents, R-gene® and M.W.S. r-gene® (Multi-Well System) real-time PCR kit ranges provide rapid, sensitive
and specific detection of viruses and bacteria. Time-to-results for all kits is within 2 hours (after extraction). There’s an extensive menu of parameters available and, for added efficiency, these ranges let you detect and quantify various viruses in one sample or analyze various samples for one pathogen at the same time.
With ready-to-use reagents, R-gene® and M.W.S. r-gene® (Multi-Well System) real-time PCR kit ranges provide rapid, sensitive and specific detection of viruses and bacteria. Time-to-results for all kits is within 2 hours (after extraction). There’s an extensive menu of parameters available and, for added efficiency, these ranges let you detect and quantify various viruses in one sample or analyze various samples for one pathogen at the same time.
Sensitive and reproducible
- Reliable detection of pathogen
- Wide, clinically-relevant linear range for quantitative assays
- Harmonized test profiles for multiple assays in one run
- Uniform processing within the R-gene® range of products
- Uniform protocol
- Protocol to convert quantification results from copies/mL into IU/mL with WHO International Standards (available for CMV R-gene®, EBV R-gene® and Parvovirus B19 R-gene®)
- Validated for use with various clinically relevant samples types
- Use manual or automated sample preparation such as NucliSENS® easyMAG® as well as assay setup platform such as easySTREAM™* liquid handling system
- Qualified with the major real-time PCR platforms
- “A la carte” testing
- Four Quantification Standards and a Sensitivity Control in quantitative assays
- Positive control and negative control, Internal control or Cell control
- Includes all necessary reagents optimized to detect and/or quantify for in vitro diagnostic use
- Ease-of-use: just add the extracted DNA or RNA sample to the ready-to-use PCR master mix and start the reaction on the appropriate Real-Time PCR thermocycler, following the optimized cycling program described in the “Instructions For Use”.
Our ARGENE® immunology range offers reference products for the detection of infectious diseases such as the CINAkit® for human CMV antigenemia tests and monoclonal antibodies for the detection of respiratory viruses and herpesviridae (CMV, HSV-1, HSV-2, VZV), HAV, etc.
- Several formats available for direct or indirect immunofluorescence
- Validated for use on clinical samples and cell culture
Fast & convenient
- CMV antigenemia results in less than 2 hours
- Same protocol for each format
- Fast results with ready-to-use FITC-labeled monoclonal antibodies in dropper-bottle
ARGENE® for infections in immunocompromised patients*
Viral infections are major causes of morbidity and mortality in immunocompromised or weakened patients (including pregnant women, transplant patients, ICU patients, or patients with AIDS, cancer, severe burns, etc.). Real-time PCR assays enable rapid and sensitive detection of various viral infections before clinical symptoms occur – helping to ensure faster, appropriate medical responses. Early management of infection ensures better patient survival and prevention of transplant rejection; quantification of the viral load and follow-up of its kinetics helps monitor treatment effectiveness.
For infection testing in immunocompromised patients, R-Gene® Real-Time PCR range offers complete CE-IVD solutions for the detection and the quantification of:
- CMV R-gene®
- CMV, HHV6, 7, 8 R-gene®
- EBV R-gene®
- BK Virus R-gene®
- HSV1 HSV2 VZV R-gene®
- Adenovirus R-gene®
- NEW: Parvovirus B19 R-gene®
*Not for donor screening
ARGENE® for respiratory infections
Acute respiratory infections, mainly caused by bacterial or viral pathogens, are responsible for numerous hospitalizations of children. The most serious and potentially life-threatening pneumopathies mostly affect young children, the elderly, immunocompromised patients or weakened individuals (e.g. with chronic disease, cancer, intensive care). Establishing a fast and reliable emergency diagnosis is essential for correct patient management and prevention of disease spread. Since symptoms are similar, appropriate diagnostic tools are necessary for the identification of infectious agents.
ARGENE® Respiratory MWS r-gene® range includes complete CE-IVD kits for the detection of DNA and RNA pathogens:
- Influenza A/B r-gene®
- RSV/hMPV r-gene®
- Rhino & EV/Cc r-gene®
- AdV/ hBoV r-gene®
- Chla/Myco pneumo r-gene®
- HCoV/HPIV r-gene®
- Legio pneumo/Cc r-gene®*
Also available: BORDETELLA R-gene® and Bordetella parapertussis r-gene®
ARGENE® for central nervous system infections
Viruses are the leading cause of meningitis and meningoencephalitis, before bacteria and fungi. Although most viral central nervous system (CNS) infections are benign, some, such as herpetic menigoencephalitis, can have dramatic outcomes and need a rapid initiation of antiviral therapy. Rapid identification of viruses implicated in central nervous system infections is therefore key to efficient patient management and for better patient outcomes.
Our ARGENE® range of products offers CE-IVD real-time molecular assays for the detection of pathogens responsible for CNS infections:
|ARGENE® Real-Time PCR kits|
|Adenovirus R-gene®||Ref. 69-010B*||Genomic detection and quantification of Adenovirus virus||90 tests|
|AdV/hBoV r-gene®||Ref. 71-043||Duplex amplification and detection of Adenovirus (A,B,C,D,E,F,G) and Bocavirus (hBoV 1,2,3,4)||60 tests|
|BK Virus R-gene®||Ref. 69-013B*||Genomic detection and quantification of BK virus||90 tests|
|Bordetella parapertussis r-gene®||Ref. 71-012||Genomic detection of Bordetella parapertussis||60 tests|
|BORDETELLA R-gene®||Ref. 69-011B*||Genomic detection of Bordetella pertussis||60 tests|
|Chla/Myco pneumo r-gene®||Ref. 71-044||Duplex detection of Chlamydia pneumoniae and Mycoplasma pneumoniae||60 tests|
|CMV HHV6,7,8 R-gene®||Ref. 69-100B*||Genomic detection and quantification of CMV and HHV-6 Genomic identification of HHV-7 and HHV-8||140 tests|
|CMV R-gene®||Ref. 69-003B*||Genomic detection and quantification of CMV||90 tests|
|EBV R-gene®||Ref. 69-002B*||Genomic detection and quantification of EBV||90 tests|
|Enterovirus R-gene®||Ref. 69-005B*||Genomic detection of Enterovirus||90 tests|
|HCoV/HPIV r-gene® r-gene®||Ref. 71-045||Duplex detection of both human coronaviruses (NL63, OC43, HKU1, 229E) and parainfluenza viruses (PIV1, 2, 3, 4).||60 tests|
|HSV1 HSV2 VZV R-gene®||Ref. 69-004B*||Genomic detection and quantification of HSV1, HSV2, VZV||180 tests|
|Influenza A(M) Group & H1N1 2009 r-gene®||Ref. 71-300||Genomic detection of Influenza A viruses and discrimination of Influenza A/H1N12009 strain||60 tests|
|Influenza A/B r-gene®||Ref. 71-040||Duplex detection of Influenza A and Influenza B||60 tests|
|Parechovirus r-gene®||Ref. 71-020||Genomic detection of Parechovirus||60 tests|
|Parvovirus B19 R-gene®||Ref. 69-019B*||Genomic detection and quantification of Parvovirus B19||90 tests|
|Rhino&EV/Cc r-gene®||Ref. 71-042||Duplex detection of Rhinovirus (A,B,C) & Enterovirus (A,B,C,D) and cellular control||60 tests|
|RSV/hMPV r-gene®||Ref. 71-041||Duplex detection of RSV (A&B) and hMPV (A&B)||60 tests|
|ARGENE® Real-Time PCR Controls|
|CELL Control r-gene®||Ref. 71-106||Validation of the presence of cells in the sample by real-time PCR assays for DNA or RNA genomes Quantification of cells in the samples||100 reactions|
|DICO Ampli r-gene®||Ref. 71-100||DNA target inhibition control premix for real-time PCR||100 reactions|
|DICO Extra r-gene®||Ref. 71-101||Extraction and inhibition control for real-time PCR assay on DNA genomes||100 reactions|
|RICO Extra r-gene®||Ref. 71-105||Extraction and inhibition control for real-time PCR assay on RNA genomes||100 reactions|
*References with an asterisk are also available in a complete format kit including manual extraction kit.
Please check the ARGENE® catalogue to find all the reference available in this Real-Time PCR range of product.
Please contact your local bioMérieux representative for product availability.
|ARGENE® Immunology Offer|
|CINAkit® HCMV ppUL83 rapid antigenemia||Ref. 19-002
|FITC Monoclonal Antibody||Ref. 12-xxx*||650 tests|
|Purified Monoclonal Antibody||Ref. 11-xxx*||650 tests|
|Purified Monoclonal Antibody + Secondary FITC||Ref. 14-xxx*||330 tests|
|Ready-to-use FITC Monoclonal Antibody in dropper-bottle||Ref. 17-xxx*||80 tests|
*Depends on the virus. Please enquire.
Please check the ARGENE® catalogue to find all the reference available in the ARGENE® immunology range of products.
Please contact your local bioMérieux representative for product availability.
BIOMERIEUX, the blue logo, ARGENE®,R-gene®, EASYMAG® and NUCLISENS® are used, pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies. Any other name or trademark is the property of its respective owner.